CN
About Us
+
About Us
ABOUT US

About Us




Proswell Medical is leading Contract Research Organization (CRO) which provides full range of professional service for innovative biopharmaceutical and medical device industry. Our corporate mission is “to improve the diagnostic and treatment level for our patients, thereby enhancing the quality of life”.

 

We have successfully completed over 1000 clinical trials and post marketing studies in more than 20 therapeutic areas included China local trials and MRCTs.

 

As a one stop solution service provider with high quality of implementation standards, we assist our clients to enter China market faster by shortening the time required for enabling and conducting of clinical trials and reducing cost of clinical trials.



Our History
Stage 1.0 : Company Start Up and Development
Stage 1.0 : Company Start Up and Development
2004 - Proswell Establishment
2006 - Patient Recruitment Database Creation
2009 - QMS(ISO9001) Establishment
2011 - TeSMO (oldest in China site management company) Acquisition to Expand SMO Business
Stage 2.0 : Innovative Transformation
2013 - PV Service System Establishment
2013 - Granted First National Epidemic Project by Chinese Government
2014 - Granted First National Innovative Drug Project by Chinese Government
2017 - Successfully Passed Strictest GCP audit by China HA and further Obtained MA
2018 - Risk Based Management System Introduction to the Whole Process of Clinical Trial Operation Service Provision
2018 - Opening of Japan Office, Global Business Expansion Strategy Development
2019 - Opening of Technical R&D Center, Developing of Proswell own CTMS and eTMF
2020 -“Proswell University” Education Platform Establishment, Setting up of Online Seminars Streaming Service
2020 - Strategic Alliance with biggest Asia IRC Service Provider Micron
Stage 2.0 : Innovative Transformation
Stage 3.0 : Great-Leap-Forward Development
Stage 3.0 : Great-Leap-Forward Development
2021 - Proswell Medical (Guangzhou) Life Science Research Co., Ltd. was Opened to Further Strengthen Global Innovative Therapy Development
2022 - Series A Round of Financing around RMB100M was Completed, Series B Round of Financing Got Started
2022 - Proswell Own CTMS 2.0 has been Launched

Top Management Team
Corporate honors
CQC IQNet Quality Management System Certificate (English Version) 2013
CQC IQNet Quality Management System Certificate (English Version) 2013
National High-Tech Enterprise Certificate
National High-Tech Enterprise Certificate
Member of Chinese Society of Clinical Oncology (CSCO)
Member of Chinese Society of Clinical Oncology (CSCO)
Membership in China Pharmaceutical Industry Research Development Association (SINO-PhIRDA)
Membership in China Pharmaceutical Industry Research Development Association (SINO-PhIRDA)
“Top 10 Clinical Service Providers in APAC 2021”
“Top 10 Clinical Service Providers in APAC 2021”
“Top 10 most attractive CRO to invest”
“Top 10 most attractive CRO to invest”
“The Top 10 Best Clinical CRO in China” 2021
“The Top 10 Best Clinical CRO in China” 2021
“Best Clinical CRO in China” National Kunpeng Reward 2019
“Best Clinical CRO in China” National Kunpeng Reward 2019
Beijing Pharmaceutical Clinical Trials Platform - Excellent CRO Company 2018
Beijing Pharmaceutical Clinical Trials Platform - Excellent CRO Company 2018
Contract Organization Research Union (CROU) - Vice Chairman and The First Council of The Union
Contract Organization Research Union (CROU) - Vice Chairman and The First Council of The Union
Vice Chairman of Clinical Research Service Working Committee of China Biomedical Industry Chain Innovation and Transformation Alliance
Vice Chairman of Clinical Research Service Working Committee of China Biomedical Industry Chain Innovation and Transformation Alliance
The first member of “Innovation R&D Service Specialty Committee” of “China Pharmaceutical Industry Research Development Association”
The first member of “Innovation R&D Service Specialty Committee” of “China Pharmaceutical Industry Research Development Association”
Member of “Clinical Research on Diabetes and Metabolic Diseases Specialty Committee” of “China Pharmaceutical Industry Research Development Association”
Member of “Clinical Research on Diabetes and Metabolic Diseases Specialty Committee” of “China Pharmaceutical Industry Research Development Association”
Member of the first Clinical Research Committee of Beijing Association of Oncology
Member of the first Clinical Research Committee of Beijing Association of Oncology
Read More